UC Announces Collaboration in Data Science Research
New fellowship program facilitated by Johnson & Johnson with UCSF and UC Berkeley to recruit data scientists for data-driven healthcare research.
Read More
Digital Health Awards to Honor Technology
UC San Francisco and Health Hub have announced the launch of the first annual UCSF Digital Health Awards to honor outstanding new digital technologies.
Read More
UC’s CRISPR Expertise to Speed Drug Discovery
Jennifer Doudna and Jonathan Weissman are the key players in a new collaboration with GlaxoSmithKline to apply CRISPR techniques to the discovery of new drug targets, potentially leading to new therapies for genetic diseases.
Read More
Tumor Regression Discovery Gets Green
Once considered an un-druggable target, a novel, small molecule approach to induce tumor regression was discovered by UCSF's Kevan Shokat, Ph.D. Now the FDA has cleared the IND application for clinical development.
Read More
Tmunity and UCSF Announce Collaboration
Tmunity agrees to exclusive license and research collaboration with UCSF's Hideho Okada, a physician-scientist and professor of neurological surgery who studies immunotherapeutic strategies aimed at malignant brain tumors.
Read Article
Scientists Create Speech From Brain Signals
A prosthetic voice decodes what the brain intends to say and generates (mostly) understandable speech, no muscle movement needed.
Read More
The Mysterious Hormone Called Klotho
Dr. Dena Dubal worked to understand how to enhance the brain's capabilities. Now she is trying to build treatments based on these results.
Read More
We Give A Big Welcome to Anthony Francis
Innovation Ventures is proud to announce the addition of Anthony Francis, Executive Director of our Office of Technology Management group.
Read All About Him
Sana Biotechnology Launches Focusing on New Class of Medicine
UCSF's Sonja Schrepfer helps found startup Sana Biotechnology, as they launch with a focus on engineering cells to create a new class of medicines.
Read Article
CRISPR-mediated Activation to Reduce Obesity
Catalyst Awardees, Nadav Ahituv, PhD and Navneet Matharu, PhD, Apply CRISPR-mediated Activation to Obesity. Here are the results:
Read Article
Mission Bio Raises $30M To Expand Tapestri’s Reach
Mission Bio raise $30M in series B funding with Adam Abate’s work on single-cell DNA analysis platform Tapestri®.
Read Article

Who We Are

Translational technology development and commercialization is a complex process because every project is unique. Innovation Ventures is dedicated to helping the UCSF community navigate those complexities by working up-close with our research faculty and promising students to really understand their science. We have a single purpose and that is to support the transition of UCSF innovation out of the lab and into the marketplace as more fully developed therapies, with a greater confidence of success. Whether evaluating a new discovery, securing funding, seeking external partnerships, or starting new companies, Innovation Ventures is here to facilitate protection, development, and commercialization of novel and valuable healing inventions.

From Innovation...

...to Impact